Important ASCO-SITC 2017 Highlights and Trends

6 key trends and highlights of note from the inaugural ASCO-SITC meeting in Orlando, Florida

March 3, 2017

Novel Way to Improve Checkpoint Inhibitor Efficacy

A look at another surprising factor that might affect efficacy of cancer immunotherapy and checkpoint blockade.

March 1, 2017

A novel immune checkpoint target

After JAK1/2 upregulation and PTEN loss, a third mechanism of resistance to checkpoint blockade has been identified. We discuss the issues around this latest challenge...

February 28, 2017